Krystal Biotech, Inc. (KRYS) Revenue 2021–2025
Krystal Biotech, Inc. (KRYS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$389.1MFY2025 · since FY2021: $0 → $389.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $389.1M | +33.9% |
| FY2024 | $290.5M | +473.0% |
| FY2023 | $50.7M | — |
| FY2022 | $0 | — |
| FY2021 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice